25 August 2022
R&D Center NovaMedica Innotech welcomed finalists of the contest among authors of opinion columns on drug development in Russia Anastasia Novikova, Alexey Veselkov and Maria Lobanova. The contest was organized by the leading website on pharmaceutics GxP News.
Competitors were students of pharmaceutics and medical universities, who needed to write an opinion column on advancement of R&D in Russian pharma. Best works will be published at gxpnews.net, and their authors will be given the status of GxP community experts and will be able to comment on GxP News materials at any time and participate in discussions with opinion leaders of the industry. They will also receive special prizes from the editorial board.
It is great to see the young and bold seize the opportunity to win!
To make sure that the students have a more integrated picture of R&D operations in Russia and of what they can write on next, NovaMedica, at the request of GxP News, invited them for a tour of our R&D Center. CEO of NovaMedica Elena Litvinova and Executive Director of NovaMedica Innotech Yulia Obidchenko were there to help the young authors find out more about pharmaceutical development.
Read more on what our guests saw, what questions they asked and what impressed them in the next issue of GxP News. Until then, below you can find a brief photo spread on the tour.
PrintGrand finale from a veritable stalwart of neuroscience
09 November 2023
Battle of pharma advocates – in search of the ideal migraine therapy
09 November 2023
31 October 2023
Long COVID study expanded across Europe
30 November 2023
Ethical, Regulatory, and Operational Considerations for Cell and Gene Therapy Research in Children
30 November 2023
Prevention, Treatment for Migraine Rapidly Evolves, Calling for Development of Novel Drugs
29 November 2023
Imaging AI hogs the spotlight at RSNA, with debuts from GE, Siemens, Philips
29 November 2023